In 2024, CEDBCAM-RI launched HOSPICARE, its first project dedicated to biocide resistance in Cameroonian hospitals, and supervised Master’s research on resistance mechanisms in hospital and environmental bacteria. HOSPICARE paved the way for HOSPICARE II, funded in 2025.
Funded research
HOSPICARE I
Whole Genome Sequencing of Biocide Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa in Healthcare Facilities in Cameroon
HOSPICARE I generates genomic data on Klebsiella pneumoniae and Pseudomonas aeruginosa that resist biocides (disinfectants and antiseptics) in hospital settings. The project characterises their resistance mechanisms, virulence and transmission dynamics to support infection prevention and control strategies against healthcare-associated infections.
Master’s research
Master’s projects carried out at CEDBCAM-RI in 2024.
HOSPICARE continues in 2025 as HOSPICARE II, a multi-site extension funded by ARES (Belgium). See the 2025 projects →

